CH3 Partners is a Funds Management, Consultancy and Financial Advisory firm focusing on the legal cannabis industry. The company specializes in assisting seed-stage to developed companies in the cannabis industry with business development, company due diligence and strategic planning for current and future growth. CH3 also assists company in fund raising directly or indirectly by leveraging off the company's three vertical approach. CH3 Partners works with companies specializing in media, marketing and licensing, legal services, financial services, cultivation and retail, delivery mechanisms, technology and life sciences, with a focus on the benefits of medicinal marijuana.
Within the CH3 framework, the Company is an advisor, investor and interim C-level/partner is numerous legal cannabis companies, including lab testing, delivery and compliance technology, ad-tech, e-commerce, research and development, consumer products, and vertically integrated licenses including cultivation, manufacturing and retail and distribution.
Company Details
- Founded
- -
- Address
- 1016 2nd Ave, New York,10022,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- http://www.ch3am.com
- Keywords
- Syracruse.
- HQ
- New York
Ch3 Partners Questions
Ch3 Partners's website is http://www.ch3am.com
Ch3 Partners's LinkedIn profile is https://www.linkedin.com/company/ch3-partners
Ch3 Partners's industry is
Investment Management
Ch3 Partners's top competitors are
Fiftyshot,
Biotrax Testing Laboratory, Inc.,
Pinnacle Analytics,
Certainty Analytical Labs,
Introspective Arts Llc,
Dark Star Cannabis,
Cannametrix,
Aclassia,
Green & Gold Consulting,
Sibannac.
Ch3 Partners's categories are Investment Management
Ch3 Partners's founding year is 2016
